Autoimmune Hepatitis ✅
Related Subjects:
|Hepatitis A
|Hepatitis B
|Hepatitis D
|Hepatitis E
|Chronic liver disease
|Cirrhosis
|Alkaline phosphatase (ALP)
|Liver Function Tests
|Ascites Assessment and Management
|Budd-Chiari syndrome
|Autoimmune Hepatitis
|Primary Biliary Cirrhosis
|Primary Sclerosing Cholangitis
|Wilson disease
|Hereditary Haemochromatosis
|Alpha-1 Antitrypsin (AAT) deficiency
|Non alcoholic steatohepatitis (NASH)
|Spontaneous Bacterial Peritonitis
|Alcoholism and Alcoholic Liver Disease
|Liver Transplantation
⚠️ Autoimmune Hepatitis (AIH) is a chronic immune-mediated inflammatory liver disease caused by loss of immune tolerance to hepatocytes.
It typically causes a hepatocellular pattern of liver injury with raised ALT/AST, raised IgG and positive autoantibodies.
Untreated AIH can progress to fibrosis, cirrhosis, liver failure and hepatocellular carcinoma, but most patients respond well to immunosuppression.
ℹ️ About
- 🛡 AIH is an autoimmune liver disease, not a viral hepatitis.
- 👩 It is more common in females and can present at any age, including childhood and older adulthood.
- 🧪 Suspect AIH when hepatitis is present with negative viral tests, no clear drug/toxin cause, raised IgG and positive autoantibodies.
- 🔬 Liver biopsy typically shows interface hepatitis with lymphoplasmacytic inflammation.
- 🔁 Presentation may be insidious, acute hepatitis-like, or rarely acute liver failure.
- 🧬 AIH is associated with other autoimmune diseases such as autoimmune thyroid disease, type 1 diabetes, coeliac disease, Sjögren’s syndrome and vitiligo.
🧠 Pathophysiology
- AIH results from immune dysregulation in a genetically susceptible person.
- Autoreactive T cells target hepatocytes, causing hepatocellular inflammation and necrosis.
- Plasma cell-rich portal inflammation causes interface hepatitis, where inflammation crosses the limiting plate into periportal hepatocytes.
- Persistent inflammation drives fibrosis, bridging fibrosis and eventually cirrhosis.
- The high IgG reflects polyclonal B-cell activation and is useful for diagnosis and monitoring response.
🩺 Clinical Features
- 😴 Fatigue, malaise and anorexia.
- 🤢 Nausea, abdominal discomfort or right upper quadrant pain.
- 🟡 Jaundice, dark urine, pale stools or pruritus.
- 🦴 Arthralgia, rash, amenorrhoea or non-specific systemic symptoms.
- 🧪 May be asymptomatic and found on abnormal liver blood tests.
- 🕰 Chronic disease may present with hepatomegaly, splenomegaly, ascites, varices or other signs of cirrhosis.
- ⚡ Acute severe AIH may present with jaundice, coagulopathy and encephalopathy.
📊 Types of Autoimmune Hepatitis
| Feature |
Type 1 AIH |
Type 2 AIH |
| Frequency |
Most common form. |
Less common. |
| Typical age |
Adults and children. |
More common in children and young people. |
| Typical antibodies |
- ANA
- Anti-smooth muscle antibody (SMA)
- Anti-SLA/LP may be present
- p-ANCA may be present
|
- Anti-LKM1
- Anti-LC1 may be present
|
| Presentation |
Often insidious chronic hepatitis, but may be acute. |
Often more acute or severe; relapse risk may be higher. |
| Associations |
Other autoimmune disease is common. |
Can be associated with other autoimmune disease; anti-LKM1 targets CYP2D6. |
🧬 Associated Autoimmune Conditions
- 🦋 Autoimmune thyroid disease, including Hashimoto’s thyroiditis and Graves’ disease.
- 🍬 Type 1 diabetes mellitus.
- 🌾 Coeliac disease.
- 👁 Sjögren’s syndrome.
- 🦴 Rheumatoid arthritis or inflammatory arthropathy.
- 🎨 Vitiligo.
- 🩸 Autoimmune haemolytic anaemia, immune thrombocytopenia or other autoimmune cytopenias.
- 🧫 Primary biliary cholangitis or primary sclerosing cholangitis overlap syndromes.
🔎 Diagnosis - Key Principle
🧪 AIH is a diagnosis made from a pattern, not one single test.
The usual pattern is raised ALT/AST, raised IgG, positive autoantibodies, compatible liver biopsy and exclusion of viral hepatitis, alcohol-related liver disease, metabolic disease and drug-induced liver injury.
🧪 Investigations
- Liver blood tests: ALT/AST usually raised more than ALP/GGT, giving a hepatocellular pattern.
- Synthetic function: bilirubin, albumin, PT/INR; urgent concern if INR is prolonged or encephalopathy develops.
- Immunoglobulins: raised polyclonal IgG supports AIH and helps monitor response.
- Autoantibodies: ANA, SMA, anti-LKM1, anti-LC1 and anti-SLA/LP depending on local panels.
- Exclude viral hepatitis: HAV, HBV, HCV, HEV; consider EBV/CMV/HSV depending on context.
- Exclude metabolic/genetic causes: ferritin/transferrin saturation, caeruloplasmin/copper studies in young patients, alpha-1 antitrypsin where appropriate.
- Exclude drug-induced liver injury: prescription drugs, over-the-counter medicines, herbal products and supplements.
- Ultrasound liver: exclude biliary obstruction, vascular disease, focal lesions and assess for chronic liver disease.
- Liver biopsy: confirms compatible histology, grades inflammation and stages fibrosis unless contraindicated.
🔬 Liver Biopsy Features
- Interface hepatitis: inflammation at the portal–parenchymal interface.
- Lymphoplasmacytic infiltrate: plasma cells are typical but not always present.
- Hepatocyte rosettes and emperipolesis may be seen.
- Bridging necrosis may occur in severe disease.
- Fibrosis or cirrhosis may be present at diagnosis if disease has been longstanding.
⚠️ Complications
- Progressive fibrosis and cirrhosis.
- Portal hypertension, ascites and variceal bleeding.
- Hepatic encephalopathy in decompensated disease.
- Acute severe hepatitis or acute liver failure.
- Hepatocellular carcinoma, mainly in patients with cirrhosis.
- Relapse after treatment reduction or withdrawal.
- Complications of long-term steroids and immunosuppression, including osteoporosis and infection risk.
💊 Management - UK/NICE-Compatible Approach
- 👨⚕️ Specialist referral: suspected AIH should be referred to hepatology/gastroenterology.
- 🎯 Treatment aim: induce and maintain remission with normal ALT/AST and IgG, prevent fibrosis progression and minimise steroid toxicity.
- 💊 Induction therapy: corticosteroids such as prednisolone are used to control active inflammation.
- 💊 Steroid-sparing therapy: azathioprine is commonly added once appropriate, especially for maintenance.
- 🧬 Before azathioprine: check TPMT activity or genotype according to local policy, and monitor FBC/LFTs for myelosuppression or hepatotoxicity.
- 🔁 Maintenance: many patients need long-term immunosuppression; withdrawal is specialist-led and only considered after sustained biochemical remission.
- 💊 Alternatives: mycophenolate mofetil, tacrolimus, ciclosporin or 6-mercaptopurine may be used by specialists if intolerance or poor response occurs.
- 🦴 Bone protection: assess fracture risk, vitamin D, calcium intake and consider DEXA because corticosteroids increase osteoporosis risk.
- 💉 Vaccination: offer hepatitis A and B vaccination if non-immune; ensure routine vaccines are up to date before significant immunosuppression where possible.
- 🚫 Lifestyle: avoid alcohol excess and unnecessary hepatotoxic drugs; review herbal supplements.
- 🫀 Liver transplant: considered for acute liver failure, decompensated cirrhosis or treatment-refractory end-stage liver disease.
📈 Monitoring
- Biochemical response: monitor ALT/AST and IgG.
- Synthetic function: monitor bilirubin, albumin and INR if severe disease or cirrhosis.
- Azathioprine safety: monitor FBC and LFTs regularly, especially during initiation and dose changes.
- Steroid toxicity: monitor weight, BP, glucose, mood, infection risk, cataracts and bone health.
- Fibrosis/cirrhosis: assess fibrosis stage and monitor for portal hypertension where relevant.
- HCC surveillance: ultrasound surveillance is for patients with cirrhosis or high-risk advanced liver disease, guided by hepatology.
- Do not rely on antibody titres alone: treatment response is mainly judged by symptoms, ALT/AST, IgG and clinical status.
🚩 Urgent Referral / Admission
- 🧠 Confusion, drowsiness or encephalopathy.
- 🩸 Prolonged INR or bleeding tendency.
- 🟡 Marked jaundice with systemic illness.
- 📈 Rapidly rising ALT/AST or bilirubin.
- 🤮 Persistent vomiting or dehydration.
- 🫀 Ascites, variceal bleeding or suspected decompensated cirrhosis.
- ⚡ Suspected acute severe AIH or acute liver failure.
📝 Exam Pearls
- 👩 AIH classically affects young or middle-aged women, but it can occur at any age.
- 🧪 Typical pattern: raised ALT/AST, raised IgG, positive ANA/SMA and negative viral serology.
- 🔬 Interface hepatitis with plasma cells is the classic biopsy finding.
- 🧬 Type 1: ANA/SMA; Type 2: anti-LKM1, often younger patients.
- 💊 Treatment is immunosuppression: corticosteroids for induction, azathioprine for maintenance.
- 🧪 Check TPMT before azathioprine and monitor FBC/LFTs.
- 🚨 Encephalopathy plus INR elevation suggests acute liver failure and needs urgent specialist care.
🧠 Teaching Note
AIH is a good example of why “hepatitis” does not always mean viral infection.
The immune system targets hepatocytes, creating interface inflammation and a hepatocellular blood-test pattern.
Raised IgG reflects polyclonal immune activation and is useful because it often falls with effective treatment.
Steroids suppress the active immune attack quickly, while azathioprine allows longer-term maintenance with less steroid exposure.
📚 References & UK Resources